iBio (IBIO) EBITDA Margin (2011 - 2025)
iBio (IBIO) reported EBITDA Margin of -34563.00% for FY2026 (year ended Jun 30, 2026), down 30038.50 percentage points from -4524.50% in FY2025.
Powered by 
Analysis
iBio (IBIO) EBITDA Margin (2011 - 2025) Analysis & Trends
Dating back to FY2011, iBio's EBITDA Margin record includes 15 fiscal years.
- EBITDA Margin has a five-year change of -33332.76 percentage points (FY2021 to FY2026).
- The FY2026 figure ranks as the lowest annual EBITDA Margin in data going back to FY2011.
- According to Business Quant data, EBITDA Margin came in at -4524.50% in FY2025 (+2522.61 pp), -7047.11% in FY2024 and -1434.24% in FY2022 (-204.00 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 39.16% |
| 10 | iBio | 87.41 Mn | -177.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -5,755.00% |
| Jun 30, 2025 | -2,502.00% |
| Dec 31, 2024 | -2,112.00% |
| Jun 30, 2024 | -1,822.86% |
| Sep 30, 2023 | -9,686.00% |
| Mar 31, 2022 | -326.83% |
| Sep 30, 2021 | -5,255.95% |
| Jun 30, 2021 | -1,794.09% |
| Mar 31, 2021 | -863.40% |
| Dec 31, 2020 | -984.82% |
| Sep 30, 2020 | -1,546.34% |
| Jun 30, 2020 | -211.25% |
| Mar 31, 2020 | -3,652.08% |
| Dec 31, 2019 | -825.80% |
| Sep 30, 2019 | -3,052.78% |
| Jun 30, 2019 | -454.34% |
| Mar 31, 2019 | -633.21% |
| Dec 31, 2018 | -578.80% |
| Sep 30, 2018 | -7,793.33% |
| Jun 30, 2018 | -3,860.44% |
API Access
iBio EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();